Klotho Neurosciences Stock Performance
| KLTOW Stock | 0.09 0 1.16% |
The company secures a Beta (Market Risk) of -1.72, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Klotho Neurosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Klotho Neurosciences is expected to outperform it. At this point, Klotho Neurosciences has a negative expected return of -0.27%. Please make sure to verify Klotho Neurosciences' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Klotho Neurosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Klotho Neurosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2026. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
1 | Will Klotho Neurosciences Inc. stock benefit from sector rotation - Buy Signal Daily Technical Stock Forecast Reports - DonanmHaber | 12/19/2025 |
2 | Weekly Earnings Should I add Klotho Neurosciences Inc stock to my portfolio - Portfolio Risk Summary AI Forecast Swing Trade Picks - baoquankhu1.vn | 01/16/2026 |
3 | How Klotho Neurosciences Inc. stock compares to industry benchmarks - 2025 Risk Factors Fast Entry Momentum Trade Alerts - mfd.ru | 02/20/2026 |
| Begin Period Cash Flow | 2808.00 | |
| Total Cashflows From Investing Activities | -123.5 K | |
| Free Cash Flow | -3.1 M |
Klotho Neurosciences Relative Risk vs. Return Landscape
If you would invest 14.00 in Klotho Neurosciences on November 27, 2025 and sell it today you would lose (5.38) from holding Klotho Neurosciences or give up 38.43% of portfolio value over 90 days. Klotho Neurosciences is currently producing negative expected returns and takes up 10.973% volatility of returns over 90 trading days. Put another way, 98% of traded stocks are less volatile than Klotho, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Klotho Neurosciences Target Price Odds to finish over Current Price
The tendency of Klotho Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.09 | 90 days | 0.09 | about 84.24 |
Based on a normal probability distribution, the odds of Klotho Neurosciences to move above the current price in 90 days from now is about 84.24 (This Klotho Neurosciences probability density function shows the probability of Klotho Stock to fall within a particular range of prices over 90 days) .
Klotho Neurosciences Price Density |
| Price |
Predictive Modules for Klotho Neurosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Klotho Neurosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Klotho Neurosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Klotho Neurosciences is not an exception. The market had few large corrections towards the Klotho Neurosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Klotho Neurosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Klotho Neurosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | -1.72 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.02 |
Klotho Neurosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Klotho Neurosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Klotho Neurosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Klotho Neurosciences generated a negative expected return over the last 90 days | |
| Klotho Neurosciences has high historical volatility and very poor performance | |
| Klotho Neurosciences has some characteristics of a very speculative penny stock | |
| Klotho Neurosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (6.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Klotho Neurosciences generates negative cash flow from operations | |
| Klotho Neurosciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: How Klotho Neurosciences Inc. stock compares to industry benchmarks - 2025 Risk Factors Fast Entry Momentum Trade Alerts - mfd.ru |
Klotho Neurosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Klotho Stock often depends not only on the future outlook of the current and potential Klotho Neurosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Klotho Neurosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.2 M | |
| Cash And Short Term Investments | 63.7 K | |
| Shares Float | 66.2 M |
Klotho Neurosciences Fundamentals Growth
Klotho Stock prices reflect investors' perceptions of the future prospects and financial health of Klotho Neurosciences, and Klotho Neurosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Klotho Stock performance.
| Return On Equity | -1.98 | |||
| Return On Asset | -0.72 | |||
| EBITDA | (5.79 M) | |||
| Net Income | (6.15 M) | |||
| Total Debt | 271.75 K | |||
| Book Value Per Share | 0.14 X | |||
| Cash Flow From Operations | (2.95 M) | |||
| Total Asset | 2.46 M | |||
| Retained Earnings | (10.56 M) | |||
| Working Capital | (1.09 M) | |||
About Klotho Neurosciences Performance
Evaluating Klotho Neurosciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Klotho Neurosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Klotho Neurosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (44.82) | (47.06) | |
| Return On Capital Employed | (5.27) | (5.00) | |
| Return On Assets | (2.88) | (2.73) | |
| Return On Equity | (5.97) | (5.67) |
Things to note about Klotho Neurosciences performance evaluation
Checking the ongoing alerts about Klotho Neurosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Klotho Neurosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Klotho Neurosciences generated a negative expected return over the last 90 days | |
| Klotho Neurosciences has high historical volatility and very poor performance | |
| Klotho Neurosciences has some characteristics of a very speculative penny stock | |
| Klotho Neurosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (6.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Klotho Neurosciences generates negative cash flow from operations | |
| Klotho Neurosciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: How Klotho Neurosciences Inc. stock compares to industry benchmarks - 2025 Risk Factors Fast Entry Momentum Trade Alerts - mfd.ru |
- Analyzing Klotho Neurosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Klotho Neurosciences' stock is overvalued or undervalued compared to its peers.
- Examining Klotho Neurosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Klotho Neurosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Klotho Neurosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Klotho Neurosciences' stock. These opinions can provide insight into Klotho Neurosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Klotho Stock Analysis
When running Klotho Neurosciences' price analysis, check to measure Klotho Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klotho Neurosciences is operating at the current time. Most of Klotho Neurosciences' value examination focuses on studying past and present price action to predict the probability of Klotho Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klotho Neurosciences' price. Additionally, you may evaluate how the addition of Klotho Neurosciences to your portfolios can decrease your overall portfolio volatility.